Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21386449 | 0.79 | TSHR (0.41) | TSHR | |
| SCHEMBL22276013 | 0.75 | TSHR (0.37) | TSHR | |
| SCHEMBL24354405 | 0.72 | TSHR (0.35) | TSHR | |
| SCHEMBL21386439 | 0.70 | TSHR (0.33) | TSHR | |
| SCHEMBL24354403 | 0.69 | TSHR (0.38) | TSHR | |
| SCHEMBL22745886 | 0.69 | TSHR (0.38) | TSHR | |
| SCHEMBL8408015 | 0.69 | TSHR (0.45) | TSHR | |
| SCHEMBL20732227 | 0.67 | TSHR (0.31) | TSHR | |
| SCHEMBL24261133 | 0.67 | TSHR (0.43) | TSHR | |
| SCHEMBL9017102 | 0.67 | TSHR (0.43) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220119555-A1 | BISSILYLAMINO-FUNCTIONALIZED CONJUGATED DIENES, THEIR PREPARATION AND THEIR USE IN THE PRODUCTION OF RUBBERS | SYNTHOS DWORY 7 SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (PL) | 2022-04-21 | — | — | US | disclosed |
| WO-2020152332-A1 | BISSILYLAMINO-FUNCTIONALIZED CONJUGATED DIENES, THEIR PREPARATION AND THEIR USE IN THE PRODUCTION OF RUBBERS | SYNTHOS S.A. (PL) | 2020-07-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220119555-A1 | BISSILYLAMINO-FUNCTIONALIZED CONJUGATED DIENES, THEIR PREPARATION AND THEIR USE IN THE PRODUCTION OF RUBBERS | CARM1, ILK, RIF1 | TSHR 3100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.